segunda-feira, setembro 19, 2011

Dominó farmacêutico?

E se isto "Remédios em risco nas unidades públicas" for o primeiro passo para isto "China and India Making Inroads in Biotech Drugs":
.
"Chinese and Indian drug makers have taken over much of the global trade in medicines and now manufacture more than 80 percent of the active ingredients in drugs sold worldwide. But they had never been able to copy the complex and expensive biotech medicines increasingly used to treat cancer, diabetes and other diseases in rich nations like the United States — until now.
.
"These generic drug companies say they are on the verge of selling cheaper copies of such huge sellers as Herceptin for breast cancer, Avastin for colon cancer, Rituxan for non-Hodgkin’s lymphoma and Enbrel for rheumatoid arthritis. Their entry into the market in the next year — made possible by hundreds of millions of dollars invested in biotechnology plants — could not only transform the care of patients in much of the world but also ignite a counterattack by major pharmaceutical companies and diplomats from richer countries."
Aposto que o governo grego apoiará os esforços chineses e indianos...

Sem comentários: